The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double‐blind, placebo‐controlled randomized trial
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods.
Aickin, M., & Gensler, H. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.5.726 · Cited by 1,346
Research works printed but not linked: 32
- Jaff, 2011, Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association, Circulation, 1, 1788, 10.1161/CIR.0b013e318214914f · DOI · Paper page
- Torbicki, 2008, Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC), Eur Heart J, 29, 2276, 10.1093/eurheartj/ehn310 · DOI · Paper page
- Holbrook, 2012, Evidence‐based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines, Chest, 141, e152S, 10.1378/chest.11-2295 · DOI · Paper page
- Worster, 2007, Evidence‐based emergency medicine/critically appraised topic. Thrombolytic therapy for submassive pulmonary embolism?, Ann Emerg Med, 50, 78, 10.1016/j.annemergmed.2007.01.002 · DOI
- Dong, 2009, Thrombolytic therapy for pulmonary embolism, Cochrane Database Syst Rev, CD004437
- Pollack, 2011, Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry), J Am Coll Cardiol, 57, 700, 10.1016/j.jacc.2010.05.071 · DOI · Paper page
- Stein, 2012, Trends in case fatality rate in pulmonary embolism according to stability and treatment, Thromb Res, 130, 841, 10.1016/j.thromres.2012.07.011 · DOI
- 2012, Am Heart J, 163, 33, 10.1016/j.ahj.2011.10.003 · DOI
- Kline, 2013, Rationale and methodology for a multicentre randomised trial of fibrinolysis for pulmonary embolism that includes quality of life outcomes, Emerg Med Australas, 25, 515, 10.1111/1742-6723.12159 · doi:10.1111/1742-6723.12159
- Klok, 2010, Quality of life in long‐term survivors of acute pulmonary embolism, Chest, 138, 1432, 10.1378/chest.09-2482 · DOI · Paper page
- Klok, 2010, Prevalence and potential determinants of exertional dyspnea after acute pulmonary embolism, Respir Med, 104, 1744, 10.1016/j.rmed.2010.06.006 · DOI
- Klok, 2008, Persistent dyspnea complaints at long‐term follow‐up after an episode of acute pulmonary embolism: results of a questionnaire, Eur J Intern Med, 19, 625, 10.1016/j.ejim.2008.02.006 · DOI
- Kline, 2009, Prospective evaluation of right ventricular function and functional status six months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure, Chest, 136, 1202, 10.1378/chest.08-2988 · DOI
- Fasullo, 2011, Six‐month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin, Am J Med Sci, 341, 33, 10.1097/MAJ.0b013e3181f1fc3e · DOI
- Sharifi, 2013, Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial), Am J Cardiol, 111, 273, 10.1016/j.amjcard.2012.09.027 · DOI · Paper page
- Otero, 2011, Echocardiographic assessment of pulmonary arterial pressure in the follow‐up of patients with pulmonary embolism, Thromb Res, 127, 303, 10.1016/j.thromres.2010.12.010 · DOI
- Kahn, 2008, Physical activity in patients with deep venous thrombosis: a systematic review, Thromb Res, 122, 763, 10.1016/j.thromres.2007.10.011 · DOI
- Vazquez, 2009, Contemporary issues in the prevention and management of postthrombotic syndrome, Ann Pharmacother, 43, 1824, 10.1345/aph.1M185 · DOI
- Kline, 2006, Surrogate markers for adverse outcomes in normotensive patients with pulmonary embolism, Crit Care Med, 34, 2773, 10.1097/01.CCM.0000241154.55444.63 · DOI
- Kubo, 2004, Development and validation of a patient questionnaire to determine New York Heart Association classification, J Card Fail, 10, 228, 10.1016/j.cardfail.2003.10.005 · DOI
- Hays, 1993, The Rand 36‐item health survey 1.0, Health Econ, 2, 217, 10.1002/hec.4730020305 · DOI · Paper page
- Kahn, 2006, VEINES‐QOL/Sym questionnaire was a reliable and valid disease‐specific quality of life measure for deep venous thrombosis, J Clin Epidemiol, 59, 1049, 10.1016/j.jclinepi.2005.10.016 · DOI · Paper page
- Stevinson, 2007, Echocardiographic and functional cardiopulmonary problems 6 months after first‐time pulmonary embolism in previously healthy patients, Eur Heart J, 28, 2517, 10.1093/eurheartj/ehm295 · DOI · Paper page
- Becattini, 2010, Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism, Thromb Res, 125, e82, 10.1016/j.thromres.2009.09.017 · DOI · Paper page
- Erkens, 2010, Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism, Cochrane Database Syst Rev, CD001100
- van Es, 2013, Quality of life after pulmonary embolism as assessed with SF‐36 and PEmb‐QoL, Thromb Res, 132, 500, 10.1016/j.thromres.2013.06.016 · DOI
- Nieto, 2013, Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism, Thromb Res, 132, 175, 10.1016/j.thromres.2013.06.019 · DOI
- Montori, 2005, Randomized trials stopped early for benefit: a systematic review, JAMA, 294, 2203, 10.1001/jama.294.17.2203 · DOI · Paper page
- Sharma, 2000, Long‐term benefit of thrombolytic therapy in patients with pulmonary embolism, Vascular Medicine, 5, 91, 10.1177/1358836X0000500205 · DOI
- Lewis, 2013, Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases, Circulation, 128, 1470, 10.1161/CIRCULATIONAHA.112.000667 · DOI · Paper page
- Puhan, 2007, Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other health‐related quality of life instruments for patients with chronic lung disease, Respir Med, 101, 308, 10.1016/j.rmed.2006.04.023 · DOI
- Penaloza, 2012, European and American suspected and confirmed pulmonary embolism populations: comparison and analysis, J Thromb Haemost, 10, 375, 10.1111/j.1538-7836.2012.04631.x · DOI
Cited by
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz405 · Cited by 4,916
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
Ortel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A., Hutten, B. A., Jaff, M. R., Manja, V., Schulman, S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001830 · Cited by 1,489
“Summary of the evidence We identified 29 systematic reviews(151-179) and 26 RCTs (n 5 2787).(130,180-204) Trials included individuals with an objectively confirmed symptomatic PE.”
BackgroundAntithrombotic Therapy for VTE Disease
Stevens, S. M., Woller, S. C., Kreuziger, L. B., Bounameaux, H., Doerschug, K., Geersing, G.-J., Huisman, M. V., Kearon, C., King, C. S., Knighton, A. J., et al. (2021) · Chest · doi:10.1016/j.chest.2021.07.055 · Cited by 1,043
Metadata
- Authors
- Kline, J. A., Nordenholz, K. E., Courtney, D. M., Kabrhel, C., Jones, A. E., Rondina, M. T., Diercks, D. B., Klinger, J. R., & Hernandez, J.
- Venue
- Journal of Thrombosis and Haemostasis
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 12
- Issue
- 4
- Pages
- 459-468
- ISSN
- 1538-7836 (ISSN-L)
- OpenAlex
- W1978243757
- Cited by
- 291
- References
- 3
- FWCI
- 23.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3141 d)
- Funders
- Genentech, Inc
- National Institutes of Health
- Radiometer, Alere, DOD
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double‐blind, placebo‐controlled randomized trial. https://app.cochat.ai/papers/10.1111/jth.12521
- The paper
- Kline, J. A., Nordenholz, K. E., Courtney, D. M., Kabrhel, C., Jones, A. E., Rondina, M. T., Diercks, D. B., Klinger, J. R., & Hernandez, J. (2014). Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double‐blind, placebo‐controlled randomized trial. Journal of Thrombosis and Haemostasis. https://doi.org/10.1111/jth.12521
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.